FindTrial
Sign In

Metformin for the Treatment of Diabetes in Pregnancy

Metformin for the Treatment of Diabetes in Pregnancy

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00414245
Enrollment
200
Registered
2006-12-21
Start date
2007-01-31
Completion date
Unknown
Last updated
2006-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Type 2, Gestational Diabetes

Brief summary

The purpose of this study is to determine whether metformin is effective and safe in the treatment of diabetes in pregnancy.

Interventions

DRUGmetformin

Sponsors

Soroka University Medical Center
Lead SponsorOTHER
Ben-Gurion University of the Negev
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* pregnant women * GDM A2 * diabetes mellitus type 2 * singleton pregnancy

Exclusion criteria

* diabetic nephropathy or proliferative retinopathy * cannot swallow tablets

Design outcomes

Primary

MeasureTime frame
glycemic control—
pregnancy complications—

Countries

Israel

Contacts

Primary ContactBoaz Sheizaf, MD
bsheizaf@bgu.ac.il972-54-2401191

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026